6.84
price down icon0.87%   -0.06
after-market Handel nachbörslich: 6.90 0.06 +0.88%
loading

Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten

pulisher
Nov 24, 2025

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - The Manila Times

Nov 24, 2025
pulisher
Nov 22, 2025

CNS Pharmaceuticals Increases Authorized Shares for Growth - The Globe and Mail

Nov 22, 2025
pulisher
Nov 21, 2025

CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

How strong is CNS Pharmaceuticals Inc. stock revenue growthWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How CNS Pharmaceuticals Inc. stock responds to policy changesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can CNS Pharmaceuticals Inc. stock outperform in 2025 bull marketAnalyst Downgrade & Entry and Exit Point Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is CNS Pharmaceuticals Inc. stock gaining market shareJuly 2025 Review & AI Optimized Trade Strategies - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is CNS Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Trend analysis for CNS Pharmaceuticals Inc. this weekJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will CNS Pharmaceuticals Inc. stock deliver better than expected guidance2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Full technical analysis of CNS Pharmaceuticals Inc. stockJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will CNS Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why CNS Pharmaceuticals Inc. stock remains resilientMarket Growth Summary & Verified Entry Point Detection - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will CNS Pharmaceuticals Inc. stock see PE expansion2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - TipRanks

Nov 17, 2025
pulisher
Nov 17, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study - Digital Journal

Nov 17, 2025
pulisher
Nov 17, 2025

CNS Pharmaceuticals (CNSP) Advances Lead Product for Brain Cance - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

CNSP Forecasts Adequate Funding to Sustain Operations into Late 2026 - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

CNS Pharmaceuticals : Reports Third Quarter 2025 Financial Results and Provides Corporate Update - MarketScreener

Nov 17, 2025
pulisher
Nov 17, 2025

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ACCESS Newswire

Nov 17, 2025
pulisher
Nov 16, 2025

Can volume confirm reversal in CNS Pharmaceuticals Inc.2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will CNS Pharmaceuticals Inc. stock return to pre crisis levelsInsider Buying & Long Hold Capital Preservation Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

MSN Money - MSN

Nov 16, 2025
pulisher
Nov 16, 2025

Will CNS Pharmaceuticals Inc. stock recover after recent drop2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is CNS Pharmaceuticals Inc. stock dividend yield sustainableEarnings Trend Report & Weekly Return Optimization Alerts - newser.com

Nov 15, 2025
$39.75
price up icon 2.13%
$30.82
price up icon 1.22%
$106.24
price up icon 4.10%
$96.54
price up icon 0.99%
biotechnology ONC
$332.71
price down icon 4.32%
$206.93
price up icon 4.11%
Kapitalisierung:     |  Volumen (24h):